Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2011; 17(12): 1606-1613
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1606
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1606
Variables | SSc | Liver cirrhosis | Controls | P-value |
The number of patients | 17 | 18 | 18 | |
Age (yr) | 47.9 ± 12.6 | 49.7 ± 9.5 | 44.4 ± 9.8 | 0.060 |
Females | 15 | 16 | 14 | 0.3801 |
Type diffuse/cutaneous | 12/5 | ND | ND | |
GI involvement | 9 | 0 | ND | 0.003 |
PAH presence | ND | 3 | ND | |
C-P score A/B | ND | 12/6 | ND | |
SLD at US (mm) | 102.3 ± 9.7 | 130.4 ± 4.6 | 100.9 ± 6.6 | 0.000 |
SARI at DUS | 0.56 ± 0.06 | 0.59 ± 0.02 | 0.52 ± 0.01 | 0.040 |
TE kPa | 5.2 ± 1.1 | ND | 4.5 ± 1 | 0.070 |
NFC grade 0/1/2/3 | 3/7/2/5 | ND | ND | |
Hypertension | 6 | 0 | 0 | 0.0011 |
ALT (U/L), median (range) | 31 (22-41) | 66.5 (36-89) | 29 (22-34) | 0.005 |
ATA/ACA/ANA positivity | 3/4/2010 | ND | ND |
- Citation: Tarantino G, Spanò A, Loi G, Parisi A, Tarantino M, Brancaccio G, Gaeta GB, Riccio A. Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis? World J Gastroenterol 2011; 17(12): 1606-1613
- URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1606.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1606